Publications by authors named "Matthew Volm"

Claim this Profile
P
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
Jasmeet Singh, Yelena Novik, Stacey Stein, Matthew Volm, Marlene Meyers

Breast Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Eleni Andreopoulou, Darci Gaiotti, Eugene Kim, Matthew Volm, Ruth Oratz

Clin Breast Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.
Jonathan D Schwartz, Max Sung, Myron Schwartz, Deborah Lehrer, John Mandeli, Matthew Volm

Oncologist· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast cancer.
Matthew D Volm

Curr Treat Options Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
Missak Haigentz, Mimi Kim, Joan Sorich, Janet Lee, Howard Hochster, Matthew Volm

Anticancer Drugs· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
Silvia C Formenti, Matthew Volm, Kristin A Skinner, Darcy Spicer, Deidre Cohen

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis